Literature DB >> 10520844

Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome.

S J Vanner1, W T Depew, W G Paterson, L R DaCosta, A G Groll, J B Simon, M Djurfeldt.   

Abstract

OBJECTIVE: Our aim was to examine the predictive value of the Rome criteria and absence of so-called "red flags" of clinical practice for diagnosing irritable bowel syndrome. Red flags were relevant abnormalities on physical examination, documented weight loss, nocturnal symptoms, blood in stools, history of antibiotic use, and family history of colon cancer.
METHODS: In retrospective studies, 98 patients who had one or more Rome criteria and lacked red flags were identified by chart review of a 1-yr period. In prospective studies, 95 patients were identified who met the Rome criteria and lacked red flags. Sensitivity, specificity, predictive value of Rome criteria, and absence of red flags were determined. Consultant's final diagnosis was the gold standard. Investigations before and after referral were recorded and reason for referral was determined in prospective studies.
RESULTS: In the retrospective series, the Rome criteria and absence of red flags had a sensitivity of 65%, specificity of 100%, and positive predictive value of 100%. None of these patients required revision of their diagnosis during a 2-yr follow-up. In the prospective study, the positive predictive value was 98%. More than 50% of the patients in this group had been referred because of diagnostic uncertainty and 24% had had an abdominal ultrasound; 66% of those <45 yr old underwent at least partial colonic evaluation.
CONCLUSIONS: These findings suggest that the Rome criteria combined with a lack of red flags have a very high predictive value for diagnosing irritable bowel syndrome. Application of these diagnostic criteria has the potential to alter utilization of health care resources.

Entities:  

Mesh:

Year:  1999        PMID: 10520844     DOI: 10.1111/j.1572-0241.1999.01437.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  55 in total

1.  Rectal passage of intestinal endometriosis.

Authors:  R L Barclay; J B Simon; S J Vanner; D J Hurlbut; J F Jeffrey
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 2.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 3.  Acupuncture for treatment of irritable bowel syndrome.

Authors:  Eric Manheimer; Ke Cheng; L Susan Wieland; Li Shih Min; Xueyong Shen; Brian M Berman; Lixing Lao
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

Authors:  William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

5.  Depression in patients with irritable bowel syndrome in Jos, Nigeria.

Authors:  Nimzing-G Ladep; Taiwo-J Obindo; Moses-D Audu; Edith-N Okeke; Abraham-O Malu
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 6.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

7.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

8.  Adequate relief in a treatment trial with IBS patients: a prospective assessment.

Authors:  Maria C F Passos; Anthony J Lembo; Lisa A Conboy; Ted J Kaptchuk; John M Kelly; Mary T Quilty; Catherine E Kerr; Eric E Jacobson; Rong Hu; Elizabeth Friedlander; Douglas A Drossman
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

9.  Treatment of Irritable Bowel Syndrome.

Authors:  Robin C. Spiller
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

10.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.